Rabeb M Ghali1, Maryam A Al-Mutawa2, Abrar K Al-Ansari2, Sonia Zaied3, Hanen Bhiri3, Touhami Mahjoub4, Wassim Y Almawi5. 1. Laboratory of Human Genome and Multifactorial Diseases (LR12ES07), Faculty of Pharmacy of Monastir, University of Monastir, Tunisia; Faculty of Sciences of Bizerte, University of Carthage, Tunisia. 2. Faculty of Sciences, Universite' de Tunis El Manar, Tunis, Tunisia. 3. Department of Clinical Oncology, CHU Fattouma Bourguiba, Monastir, Tunisia. 4. Laboratory of Human Genome and Multifactorial Diseases (LR12ES07), Faculty of Pharmacy of Monastir, University of Monastir, Tunisia. 5. Faculty of Sciences, Universite' de Tunis El Manar, Tunis, Tunisia; School of Pharmacy, Lebanese American University, Byblos, Lebanon. Electronic address: wassim.almawi@lau.edu.lb.
Abstract
BACKGROUND: Estrogen is key to breast cancer pathogenesis, and acts by binding its receptor (ER), which exists as ERα and ERβ, encoded by ESR1 and ESR2 genes, respectively. Studies that investigated the association of ESR1 and ESR2 variants with breast cancer yielded mixed outcome, and ethnic contribution was proposed. We evaluated the association between ESR1 and ESR2 variants and breast cancer and associated features in Tunisian women. METHODS: Retrospective case-control study involving 207 female breast cancer patients, and 284 control women. Genotyping was done by real-time PCR. RESULTS: Minor allele frequencies (MAF) of tagging SNPs rs2234693 and rs3798577 (ESR1) were significantly higher, while MAF of rs1256049 (ESR2) was significantly lower in breast cancer patients vs. CONTROLS: Patients carrying rs3798577 genotypes had higher risk, while rs1256049 genotype carriers had reduced risk of breast cancer. The association of ESR1 and ESR2 gene variants with breast cancer depended on ER and Her-2 status. ESR1 rs3798577 and ESR2 rs1256049 were associated with breast cancer in ER-positive cases, and ESR1 rs2234693, and rs3798577 were associated with breast cancer in Her-2-negative cases, while the association of ESR2 rs1256049 with breast cancer was seen in Her-2 positive cases. Haploview analysis identified 4-locus ESR1 haplotypes that were positively (CGTT, TACC, and TACT), and negatively (CGTC) associated with breast cancer. No ESR2 haplotypes associated with breast cancer were identified. CONCLUSION: ESR1 alleles and genotypes, and specific 3-locus ESR1 haplotypes are related with increased breast cancer susceptibility in Tunisian women. However, ESR2 variant and specific 1-locus ESR1 haplotype have a protective effect.
BACKGROUND: Estrogen is key to breast cancer pathogenesis, and acts by binding its receptor (ER), which exists as ERα and ERβ, encoded by ESR1 and ESR2 genes, respectively. Studies that investigated the association of ESR1 and ESR2 variants with breast cancer yielded mixed outcome, and ethnic contribution was proposed. We evaluated the association between ESR1 and ESR2 variants and breast cancer and associated features in Tunisian women. METHODS: Retrospective case-control study involving 207 female breast cancerpatients, and 284 control women. Genotyping was done by real-time PCR. RESULTS: Minor allele frequencies (MAF) of tagging SNPs rs2234693 and rs3798577 (ESR1) were significantly higher, while MAF of rs1256049 (ESR2) was significantly lower in breast cancerpatients vs. CONTROLS: Patients carrying rs3798577 genotypes had higher risk, while rs1256049 genotype carriers had reduced risk of breast cancer. The association of ESR1 and ESR2 gene variants with breast cancer depended on ER and Her-2 status. ESR1rs3798577 and ESR2rs1256049 were associated with breast cancer in ER-positive cases, and ESR1rs2234693, and rs3798577 were associated with breast cancer in Her-2-negative cases, while the association of ESR2rs1256049 with breast cancer was seen in Her-2 positive cases. Haploview analysis identified 4-locus ESR1 haplotypes that were positively (CGTT, TACC, and TACT), and negatively (CGTC) associated with breast cancer. No ESR2 haplotypes associated with breast cancer were identified. CONCLUSION:ESR1 alleles and genotypes, and specific 3-locus ESR1 haplotypes are related with increased breast cancer susceptibility in Tunisian women. However, ESR2 variant and specific 1-locus ESR1 haplotype have a protective effect.
Authors: Martha Patricia Gallegos-Arreola; Guillermo M Zúñiga-González; Luis E Figuera; Ana María Puebla-Pérez; María Guadalupe Márquez-Rosales; Belinda Claudia Gómez-Meda; Mónica Alejandra Rosales-Reynoso Journal: PeerJ Date: 2022-05-10 Impact factor: 3.061
Authors: Danny Houtsma; Stefanie de Groot; Renee Baak-Pablo; Elma Meershoek-Klein Kranenbarg; Caroline M Seynaeve; Cornelis J H van de Velde; Stefan Böhringer; Judith R Kroep; Henk -Jan Guchelaar; Hans Gelderblom Journal: Sci Rep Date: 2021-02-05 Impact factor: 4.379
Authors: Myra Langendonk; Mathilde R W de Jong; Nienke Smit; Jonas Seiler; Bart Reitsma; Emanuele Ammatuna; Andor W J M Glaudemans; Anke van den Berg; Gerwin A Huls; Lydia Visser; Tom van Meerten Journal: Blood Cancer J Date: 2022-03-07 Impact factor: 11.037